1. A comparison of four common malnutrition risk screening tools for detecting cachexia in patients with curable gastric cancer
- Author
-
Xian-Zhong Zhang, Xian Shen, Zhong-Chen Liu, Xiao-Lei Chen, Xi-Yi Chen, Zhen Yu, Dong-Lei Zhou, Bing-Wei Ma, Bo Li, and Cheng-Le Zhuang
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Cachexia ,Endocrinology, Diabetes and Metabolism ,Nutritional Status ,030209 endocrinology & metabolism ,Risk Assessment ,Body Mass Index ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Gastrectomy ,Stomach Neoplasms ,Internal medicine ,medicine ,Humans ,Mass Screening ,In patient ,Prospective Studies ,Nutritional risk ,Aged ,030109 nutrition & dietetics ,Nutrition and Dietetics ,Anthropometry ,Radical gastrectomy ,business.industry ,Malnutrition ,digestive, oral, and skin physiology ,Reproducibility of Results ,Cancer cachexia ,Cancer ,Middle Aged ,medicine.disease ,Nutrition Assessment ,Risk screening ,Female ,business ,human activities - Abstract
Objective Although there is international consensus regarding the importance of cachexia, no tools exist, to our knowledge, for cachexia screening among patients with cancer. The aim of this study was to evaluate whether patients with cancer and cachexia could be identified using the four most commonly used nutritional screening tools: the Malnutrition Universal Screening Tool (MUST), the Nutritional Risk Screening (NRS)-2002, the Malnutrition Screening Tool (MST), and the Short Nutritional Assessment Questionnaire (SNAQ). Methods Clinical data were prospectively collected for patients who underwent elective radical gastrectomy for gastric cancer in two large centers between August 2014 and February 2018. Patients were also screened using the MUST, NRS-2002, MST, and SNAQ tools. The screening results were subsequently compared with the international consensus diagnostic criteria for cancer cachexia. Results A total of 1001 patients were evaluated, including 363 patients (36.3%) with cancer cachexia. Among the patients “at nutritional risk” based on each tool, the proportions of cachexia were 87.3% for the MUST tool, 84.3% for the MST tool, 76.6% for the NRS-2002 tool, and 54.3% for the SNAQ tool. The MST tool provided the largest area under the curve for identifying cancer cachexia (0.914; P Conclusion Among the tools examined, the MST had the greatest ability to detect cancer cachexia among patients with gastric cancer.
- Published
- 2020
- Full Text
- View/download PDF